207 related articles for article (PubMed ID: 29603128)
21. Giant retroperitoneal Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon: A case report.
Wu D; Xu J; Wang P; Zhou S
Asian J Surg; 2023 Feb; 46(2):1014-1015. PubMed ID: 35961905
[No Abstract] [Full Text] [Related]
22. Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.
Yao W; Li K; Wang Z; Dong K; Zheng S
Pediatr Dermatol; 2020 Jul; 37(4):677-680. PubMed ID: 32212177
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome for kaposiform hemangioendothelioma: A report of two cases.
Schaefer BA; Wang D; Merrow AC; Dickie BH; Adams DM
Pediatr Blood Cancer; 2017 Feb; 64(2):284-286. PubMed ID: 27701822
[TBL] [Abstract][Full Text] [Related]
24. Impact of age and tumor size on the development of the Kasabach-Merritt phenomenon in patients with kaposiform hemangioendothelioma: a retrospective cohort study.
Zhou J; Lan Y; Qiu T; Gong X; Zhang Z; He C; Peng Q; Hu F; Zhang X; Lu G; Qiu L; Kong F; Zhang Y; Chen S; Ji Y
Precis Clin Med; 2023 Jun; 6(2):pbad008. PubMed ID: 37305527
[TBL] [Abstract][Full Text] [Related]
25. Kaposiform haemangioendothelioma of the spine associated with fixed hyperlordotic deformity and Kasabach-Merritt Syndrome: a case report and literature review.
Chin LHQ; Fung KKF; Chan JPK; Kan ANC; Yuen MK
Skeletal Radiol; 2023 Apr; 52(4):783-790. PubMed ID: 35948828
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological features of Kaposiform hemangioendothelioma.
Liu Q; Jiang L; Wu D; Kan Y; Fu F; Zhang D; Gong Y; Wang Y; Dong C; Kong L
Int J Clin Exp Pathol; 2015; 8(10):13711-8. PubMed ID: 26722599
[TBL] [Abstract][Full Text] [Related]
27. Kaposiform hemangioendothelioma presented with raynaud phenomenon: a case report.
Liu L; Gu W; Teng L; Xu Y; Zheng F; Hu M; Lu M; Xu X
BMC Pediatr; 2023 Nov; 23(1):574. PubMed ID: 37978357
[TBL] [Abstract][Full Text] [Related]
28. Bullous Kaposiform Hemangioendothelioma Masquerading as Aplasia Cutis Congenita.
Steen AJ; Shin JH; Pace NC; Edgar M; Clay MR; Linos K; Barton DT; Mann JA
Pediatr Dermatol; 2016 Sep; 33(5):e267-9. PubMed ID: 27339319
[TBL] [Abstract][Full Text] [Related]
29. Sirolimus Treatment of an Infant With Intrathoracic Kaposiform Hemangioendothelioma Complicated by Life-threatening Pleural and Pericardial Effusions.
Duan L; Renzi S; Weidman D; Waespe N; Chami R; Manson D; Cada M; Carcao M
J Pediatr Hematol Oncol; 2020 Jan; 42(1):74-78. PubMed ID: 30044355
[TBL] [Abstract][Full Text] [Related]
30. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up.
Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
Pediatr Blood Cancer; 2015 Apr; 62(4):577-80. PubMed ID: 25346262
[TBL] [Abstract][Full Text] [Related]
31. Role of Sirolimus in Advanced Kaposiform Hemangioendothelioma.
Oza VS; Mamlouk MD; Hess CP; Mathes EF; Frieden IJ
Pediatr Dermatol; 2016; 33(2):e88-92. PubMed ID: 26864138
[TBL] [Abstract][Full Text] [Related]
32. Imaging findings of Kaposiform Hemangioendothelioma in children.
Ryu YJ; Choi YH; Cheon JE; Kim WS; Kim IO; Park JE; Kim YJ
Eur J Radiol; 2017 Jan; 86():198-205. PubMed ID: 28027747
[TBL] [Abstract][Full Text] [Related]
33. Kaposiform haemangioendothelioma: magnetic resonance imaging features in 64 cases.
Peng S; Xia C; Yang K; Chen S; Ji Y
BMC Pediatr; 2021 Mar; 21(1):107. PubMed ID: 33657997
[TBL] [Abstract][Full Text] [Related]
34. [How do we treat Kaposiform Haemangioendothelioma?].
Huerta-Calpe S; Pinilla-González A; Juan Ribelles A; Gómez-Chacón Villalba J; Pérez-Tarazona S
An Pediatr (Engl Ed); 2019 Aug; 91(2):122-124. PubMed ID: 30482705
[No Abstract] [Full Text] [Related]
35. Treating kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon by intralesional injection of absolute ethanol.
Shen W; Cui J; Chen J; Zou J; Xiaoying Z
J Craniofac Surg; 2014 Nov; 25(6):2188-91. PubMed ID: 25318440
[TBL] [Abstract][Full Text] [Related]
36. Clinical and imaging features of Kaposiform Hemangioendothelioma.
Hu PA; Zhou ZR
Br J Radiol; 2018 Jun; 91(1086):20170798. PubMed ID: 29536769
[TBL] [Abstract][Full Text] [Related]
37. Laryngomalacia and complicated, life-threatening mTOR-positive Kaposiform hemangioendothelioma cured by Supraglottoplasty and sirolimus.
Schroeder U; Lauten M; Stichtenoth G; Gebhard MP; Buchholz M; Kaiser MM
Klin Padiatr; 2014 Nov; 226(6-7):362-8. PubMed ID: 24810750
[TBL] [Abstract][Full Text] [Related]
38. Multifocal Kaposiform Hemangioendothelioma in a Newborn With Confirmatory Histopathology.
Cohen OG; Florez-Pollack S; Finn LS; Larijani M; Jen M; Treat J; Adams DM; Acord MR
Pediatrics; 2022 Nov; 150(5):. PubMed ID: 36193691
[TBL] [Abstract][Full Text] [Related]
39. Vincristine and sirolimus in the treatment of kaposiform haemangioendothelioma.
Peng S; Yang K; Xu Z; Chen S; Ji Y
J Paediatr Child Health; 2019 Sep; 55(9):1119-1124. PubMed ID: 30604513
[TBL] [Abstract][Full Text] [Related]
40. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.
Wang Y; Kong L; Sun B; Cui J; Shen W
J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
